Clinical Trials on WHO Grade 3 Glioma With IDH1 Mutation in Switzerland
Total 6 results
-
University Hospital Inselspital, BerneSwiss National Science FoundationRecruitingGlioma | Brain Tumor | IDH MutationSwitzerland
-
University of California, San FranciscoNational Institute of Neurological Disorders and Stroke (NINDS); The Chad-Tough... and other collaboratorsRecruitingDiffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Diffuse Midline Glioma, H3 K27M-Mutant | Recurrent WHO Grade III Glioma | WHO Grade III GliomaUnited States, Netherlands, Israel, Australia, New Zealand, Switzerland
-
Jasper GerritsenMassachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaboratorsRecruitingGlioblastoma | Brain Neoplasms | Astrocytoma, Grade III | High-grade Glioma | Astrocytoma, Grade IV | Glioblastoma, IDH-mutant | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, Adult | Brain Neoplasm, Primary | Brain Neoplasm, Malignant | Astrocytoma, Malignant | Brain Neoplasms, AdultUnited States, Germany, Belgium, Switzerland, Netherlands
-
Sabine Mueller, MD, PhDNational Cancer Institute (NCI); Dana-Farber Cancer Institute; Mithil Prasad... and other collaboratorsRecruitingGlioblastoma | Recurrent Ependymoma | CNS Tumor | Diffuse Midline Glioma (DMG) | Recurrent Malignant Central Nervous System Neoplasm | Spinal Cord Glioma | Central Nervous System Tumor | World Health Organization (WHO) Grade III GliomaUnited States, Switzerland
-
Debiopharm International SARecruitingAstrocytoma, Grade III | Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeSpain, United States, Switzerland
-
Assistance Publique - Hôpitaux de ParisRecruitingInitial Radiological Diagnosis Eligible for Tumor Resection | Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type) | Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant TemozolomideBelgium, France, Switzerland